Two NGOs have challenged the patent protection of a leukaemia drug produced by Swiss pharmaceutical company Novartis. They complain that the patent on the drug Kymriah allows Novartis to charge inflated prices for its use on patients.
This content was published on
1 minute
swissinfo.ch/mga
Pressure groups Public Eye and Médecins du Monde have filed their objection to the European patent office in Munich. They claim that Kymriah was not invented by Novartis because the research behind the drug was carried out by public institutions.
The medicament, which is used to treat leukaemia and lymph gland cancer on patients who have not responded to previous therapies, costs CHF370,000 ($375,000) per infusion. This makes it the most expensive drug in Switzerland, say the NGOs.
If the NGOs succeed in nullifying the patent, Novartis will still be able to sell the drug but without having a monopoly that allows it to charge more.
The decisions of the Munich patent authority are binding on Switzerland despite not being a member state of the European Union. Novartis told the Swiss news agency Keystone-SDA that its lawyers are analysing the legal challenge.
More
More
How can a drug cost $2.1 million?
This content was published on
US authorities have approved a $2.1 million gene therapy, making it the most expensive drug ever. Can such a price tag be justified?
Train vs plane: would you take a direct train between London and Geneva?
Eurostar is planning to run direct trains from Britain to Germany and Switzerland from the early 2030s. Would you favour the train over the plane? If not, why not?
Switzerland presents special toilet for cows to cut emissions
This content was published on
A toilet specially designed for cows, aimed at reducing ammonia emissions per animal by 15%, was presented at a farm in Hellbühl, canton Lucerne, on Wednesday.
Swiss petition against US F-35 fighter jets gathers 42,000 signatures
This content was published on
A petition by the "Stop-F35 Alliance" urging the Swiss government to immediately halt the purchase of new US fighter jets has gathered 42,500 signatures.
Swiss House of Representatives backs online Schengen visa system
This content was published on
In future, Schengen visa applications should be made via a European Union online platform. On Tuesday, Switzerland's House of Representatives adopted a revision of Swiss legislation on this issue.
UBS study: Switzerland is still the richest country in the world
This content was published on
Average per-capita wealth in Switzerland rose last year to $687,000 (CHF561,000), the UBS Global Wealth Report said on Wednesday.
UBS and Pictet report data leak after cyber attack on provider Chain IQ
This content was published on
Swiss banks UBS and Pictet on Wednesday confirmed they had suffered a data leak due to a cyber attack on their subcontractor Chain IQ in Switzerland.
Iran will respond firmly if US gets directly involved in Israeli strikes, says UN ambassador
This content was published on
Iran says it will respond firmly to the United States if it becomes directly involved in Israel's military campaign, the Iranian ambassador to the United Nations in Geneva said on Wednesday.
Swiss politicians concerned by cut to Lausanne-Paris TGV services
This content was published on
The Vaud cantonal parliament wants to maintain six direct daily TGV high-speed train services between Lausanne and Paris.
This content was published on
Switzerland and Norway have signed a bilateral agreement for the future storage of carbon dioxide (CO2) under the North Sea.
Switzerland must better protect whistleblowers, says OECD
This content was published on
Switzerland must step up its anti-corruption efforts and provide better protection for whistleblowers while increasing fines for guilty firms, an OECD anti-bribery group says.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss healthcare costs expected to rise well above inflation
This content was published on
On Monday, SantésuisseExternal link outlined the main reasons for the expected increases in health insurance policies. It predicts a 6% rise in physiotherapy treatments, the same greater demand for care for the elderly and in nursing homes and 5% extra medical diagnostics being performed in laboratories. In addition, insurers expect costs to rise to a…
Generic drugs remain twice as expensive in Switzerland
This content was published on
Drug prices in Switzerland remain higher than in other major European markets, especially when it comes to generic drugs, which are twice as expensive in Switzerland as elsewhere.
This content was published on
Curing cancer for the masses could be challenging if healthcare systems are crippled by rapidly rising cancer drug prices.
WHO adopts watered-down resolution on drug transparency
This content was published on
The World Health Organization (WHO) has adopted a resolution to improve transparency on drug prices but some people say it doesn't go far enough.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.